Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT01194440
What this trial is testing

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Who this might be right for
Ductal Carcinoma in SituEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Not applicableLooking for participantsNCT06867484
What this trial is testing

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Who this might be right for
Breast CancerCancerCancer of the Breast+3 more
Youssef Zeidan 114
Not applicableStudy completedNCT00283608
What this trial is testing

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 1,000
Not applicableStudy completedNCT02752893
What this trial is testing

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 10
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Study completedNCT03184090
What this trial is testing

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

Who this might be right for
Metastatic Breast Cancer
MedSIR 33
Early research (Phase 1)Active Not RecruitingNCT05509790
What this trial is testing

LY3484356 in Chinese Participants With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 17
Not applicableUnknownNCT04683757
What this trial is testing

The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer

Who this might be right for
Breast Cancer
Ying Wang 288
Large-scale testing (Phase 3)Not Yet RecruitingNCT07005557
What this trial is testing

Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdjuvant Therapy
Fudan University 1,244
Testing effectiveness (Phase 2)Ended earlyNCT00498901
What this trial is testing

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Washington 1
Early research (Phase 1)Looking for participantsNCT05504707
What this trial is testing

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 30
Not applicableEnded earlyNCT01856036
What this trial is testing

Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

Who this might be right for
Breast Cancer
Saint John's Cancer Institute 2
Very early researchEnded earlyNCT04727632
What this trial is testing

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

Who this might be right for
Estrogen Receptor Positive Breast Cancer
University of Utah 2
Large-scale testing (Phase 3)Study completedNCT01598298
What this trial is testing

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Who this might be right for
Breast CancerMusculoskeletal ComplicationsPain
SWOG Cancer Research Network 299
Not applicableStudy completedNCT06343987
What this trial is testing

The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity

Who this might be right for
Metastatic Breast CancerEstrogen-receptor-positive Breast CancerAdiposity
Aarhus University Hospital 21
Large-scale testing (Phase 3)Ended earlyNCT02340221
What this trial is testing

Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Hoffmann-La Roche 631
Early research (Phase 1)Ended earlyNCT01281163
What this trial is testing

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Positive+4 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Ended earlyNCT02409316
What this trial is testing

[18F]FES PET/CT in Endocrine Refractory Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerBreast NeoplasmMetastatic Breast Cancer
University of Pennsylvania 6
Next Page